Comparison of the effect of 0.5, 2.5 and 5 mg doses of oral minoxidil in the treatment of female pattern of hereditary hormonal hair loss

Phase 2

Recruiting

• Conditions: Female pattern androgenic alopecia.; Androgenic alopecia

• Registration Number: IRCT20220322054341N1
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 2 May 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients with clinical diagnosis of female pattern hair loss
Sinclair scale one to four
Age range 18 to 50 years old
Conscious consent to enter the study and the possibility of attending visits and follow-up sessions

Exclusion Criteria

Patients taking medication other than vitamins or minerals for alopecia
Pregnancy or breastfeeding
Patients with serious internal disease, especially heart disease or comorbidities at the treatment site
Psychiatric patients
Abnormal tests at baseline

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement rate. Timepoint: 3 and 6 months after starting treatment. Method of measurement: By sinclair scale, clinical and dermatoscopic images (Determine the number and thickness of hair shafts per square centimeter).

Secondary Outcome Measures

Name	Time	Method
Safety. Timepoint: 3 and 6 months after starting treatment. Method of measurement: Asking the patient about the side effects of treatment.;Tolerability. Timepoint: 3 and 6 months after starting treatment. Method of measurement: With Investigator Assessment of Tolerability scale (zero, low, medium and high or sufficient).;Patient satisfaction. Timepoint: 3 and 6 months after starting treatment. Method of measurement: With Caregiver treatment satisfaction (CTS) questionnaire (completely satisfied, satisfied, neither satisfied nor dissatisfied, dissatisfied and completely dissatisfied).